Powell warns Trump’s steep tariffs may trigger higher inflation and slow US growth
Federal Reserve Chair Jerome Powell has raised alarm over President Donald Trump’s sweeping new tariffs, warning that the economic impact...
Federal Reserve Chair Jerome Powell has raised alarm over President Donald Trump’s sweeping new tariffs, warning that the economic impact...
Wall Street faced another brutal selloff on Friday, with major US stock indexes suffering their worst two-day decline since the...
The Nasdaq 100 Index has slumped into a technical correction this year, falling by over 16% from its highest level...
Crypto prices remained on edge on Friday as the market came to terms with Donald Trump’s trade war and its...
A moderate Democrat is expressing cautious optimism at President Donald Trump’s stance on tariffs in a stark departure from most...
A key House Republican lawmaker is moving to bring more manufacturing back to the U.S. after President Donald Trump unveiled...
President Donald Trump laid out his plans for imposing a host of new tariffs on imports to the U.S. Wednesday...
Dr. Mehmet Oz will serve as the next administrator of the Centers for Medicare and Medicaid Services after the full...
President Donald Trump’s national security advisor, Mike Waltz, has repeatedly landed in hot water in recent days, beginning with an...
Two senior lawmakers have introduced a bipartisan bill that would reassert Congress’ powers over U.S. tariffs, a day after President...
Disclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.